LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer

Table 2 mRNA expression of LRRC15 and PDPN in TGF-beta-treated and untreated MRC-5 cells

Group1	Group2	Number	Min	Max	Median	IQR	Lower quartile	Upper quartile	Mean	SD	SE
PDPN	MRC5	3	0.800	1.368	0.913	0.284	0.857	1.141	1.027	0.301	0.174
PDPN	MRC5 + TGF-β	3	6.100	7.271	6.463	0.586	6.282	6.867	6.612	0.599	0.346
LRRC15	MRC5	3	0.255	2.349	1.669	1.047	0.962	2.009	1.424	1.068	0.617
LRRC15	MRC5 + TGF-β	3	5.189	6.553	6.171	0.682	5.680	6.362	5.971	0.704	0.406

Statistical description of the mRNA expression of LRRC15 and PDPN in TGF-beta-treated and untreated MRC-5 cells: In the PDPN group, the mean levels were 1.027 ± 0.301 in the MRC5 group and 6.612 ± 0.599 in the MRC5 + TGF-β group. In the LRRC15 group, the mean levels were 1.424 ± 1.068 in the MRC5 group and 5.971.0.704 in the MRC5 + TGF-β group

ISSN: 1755-8794